Live Breaking News & Updates on Eton Pharmaceuticals
Stay updated with breaking news from Eton pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Rating) was the target of a significant decline in short interest in May. As of May 15th, there was short interest totalling 530,400 shares, a decline of 9.7% from the April 30th total of 587,500 shares. Approximately 2.4% of the shares of the stock are sold short. Based on […] ....
Opaleye Management Inc. lowered its stake in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Rating) by 13.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,170,000 shares of the company’s stock after selling 351,000 shares during the quarter. Eton Pharmaceuticals […] ....
Corrado Advisors LLC lessened its holdings in shares of Harrow Health, Inc. (NASDAQ:HROW – Get Rating) by 14.9% during the fourth quarter, HoldingsChannel reports. The fund owned 16,314 shares of the company’s stock after selling 2,846 shares during the period. Corrado Advisors LLC’s holdings in Harrow Health were worth $241,000 at the end of the […] ....
Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Rating) was the recipient of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 587,500 shares, an increase of 7.4% from the April 15th total of 547,200 shares. Currently, 2.7% of the company’s shares are short sold. Based […] ....
Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Rating) – Equities researchers at HC Wainwright decreased their FY2024 earnings per share (EPS) estimates for shares of Eton Pharmaceuticals in a research note issued to investors on Friday, May 12th. HC Wainwright analyst R. Selvaraju now anticipates that the company will earn $0.15 per share for the year, […] ....